QuantLogix's current estimate for AliveCor, published 2026-09-27 — below the last disclosed round of $980M (2022-Q3).
Confidence
medium
Basis
secondary led
What backs this price
Last disclosed round
$980M
2022-Q3
weight 0.06
Secondary market print
$648.76M
2026-06-27
weight 0.58
How this price has held up
No round has priced for AliveCor since QuantLogix began publishing a price for it, so there is nothing to grade yet. The claim above is on the record from 2026-09-27 and will be graded against the next priced round. See the full accuracy record →
Which publicly-traded funds already hold it, what $10,000 buys, and whether any route is open to you.
Cite this price as QuantLogix QL Price, AliveCor, 2026-09-27 (fd67c503eaf04cef).
The id pins this exact claim, so a citation stays checkable after the price moves.
Model estimate for research — not a quote, target price, or investment advice.
IPO Outlookprivate
Is AliveCor going public?
No. AliveCor is private and has not filed to go public. There is no S-1 on file.
What is AliveCor's valuation in 2026?
AliveCor is valued at $980M as of 2022-Q3, set by its Series F ($150M, Aug 2022). That is the last confirmed mark, not a live price — private shares do not trade continuously.
Has AliveCor filed an S-1?
No public S-1 is on file for AliveCor.
How much has AliveCor raised?
AliveCor has raised $300.97M in total, most recently a Series F of $150M in Aug 2022.
Is AliveCor publicly traded — can you buy AliveCor stock?
No. AliveCor is a private company — its shares are not listed on any exchange and there is no ticker. The routes to exposure are pre-IPO secondary marketplaces and funds (accredited investors), employee tender offers when the company runs one, and public companies with read-through exposure. QuantLogix maps every route it can verify for AliveCor on its Pre-IPO Access Desk.
Answers are derived from the roster record shown on this page — filing status, last round and confirmed marks. Where the record is silent, the answer says so rather than guessing.
Company Profile
Founded
2010
HQ
Mountain View, CA
Employees
200
Total Raised
$300.97M
Last Round
Series F — $150M (Aug 2022)
IPO Status
private
Fundraising Status
Series F · $150M · 4y 1mo ago
privateTotal raised $300.97M
Secondary Market
Implied price / share
$9.75
Last round price / share
$14.72
vs last round
-33.8%
Open interest
1
Last round price vs secondary price
Secondary price return by period
Implied per-share price from private secondary transactions, as of Jun 2026. This is a point estimate, not a quote — the feed carries no bid, ask or spread, and a secondary print is evidence of what someone paid on that date rather than a live market. Compare across every tracked name →
Latest Funding Round
Round
Amount
Date
Lead Investor
Post-Money
Series F
$150M
Aug 2022
—
$980M
Talent Signal
Hiring trend
▲ Hiring uptrend
+14% vs 2026-08
Open roles
8
via careers page
Product-build share
63%
engineering, research, product, design
Trajectory
expanding
product-led hiring — 63% of open roles build product; the rest are go-to-market and G&A.
No tracked executive churn; open roles trending up.
Open roles by month
Open roles by function
■ product-building ■ go-to-market / G&A
Clinical TrialsClinical EvidenceSoftware Engineer, iOSSenior Software Engineer, QAGraphic DesignerStrategic Sales Lead: Cardiovascular Device (ECG) - MidWest, West only
Counted from AliveCor's live job board as of 2026-09-16; role functions classified from posting titles. Open-role counts are an activity signal, not headcount. Refreshed monthly.
Health CareInformation TechnologyMedical DeviceMobileSoftware
Private-company numbers are not real-time. Reflects publicly disclosed valuations from press releases, news reports, and tender offers as of 2022-Q3. Refreshed quarterly.